Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
eTOPIX_New Sensitive ELISA Kits for Metabolic Diseases Research – Sent on 27 January 2021
If you can't see this e-mail properly, view it online |
||||||||||||||||||||||||||||||||||||||||||||||
eTOPIX Product Highlights - 27 January 2021 | www.adipogen.com | ||||||||||||||||||||||||||||||||||||||||||||||
The "Hunger Factor" ACBP A NEW & Sensitive Biomarker for Obesity Research |
||||||||||||||||||||||||||||||||||||||||||||||
Recent studies show that Acyl-CoA-binding Protein [ACBP] levels correlate with human body mass index (BMI). Increasing ACBP levels in mice trigger lipogenesis, food intake and weight gain and neutralization of ACBP increases lipolysis, reduces food intake post-starvation and causes weight loss in mice. Obese patients exhibit elevated plasma levels of ACBP, while a reduction in the ACBP mRNA and ACBP plasma concentration is observed in these patients after a substantial weight loss. ACBP might be useful for the prevention or treatment of obesity and metabolic syndrome diseases. AdipoGen Life Sciences' Acyl-CoA-binding Protein (human) ELISA Kit (Prod. No. AG-45B-0019) is a sensitive (30pg/ml) colorimetric sandwich immunoassay that detects human ACBP in serum, plasma and cell culture supernatant. It does not detect mouse ACBP.
Figure: Secretion of human ACBP during induction of autophagy is measured using the Acyl-CoA-binding Protein (human) ELISA Kit (Prod. No. AG-45B-0019). Method: Human embryonic kidney (HEK 293) (A) and B lymphoblast SKW 6.4 (B) cell lines are treated for 24 hours with different concentrations of the autophagy inducer Everolimus (Prod. No. AG-CN2-0520). Supernatants are collected, diluted and tested using the Acyl-CoA-binding Protein (human) ELISA Kit (Prod. No. AG-45B-0019). Related other ACBP Reagents!
Other STANDARD ELISAs for Metabolic Diseases Research!
|
||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||
Privacy Policy You are receiving this e-mail because you have interacted with us in some way over the past 10 years. You might have purchased products from us, had technical discussions with our staff or attended a conference sponsored by AdipoGen Life Sciences. You can always update your mailing preferences and opt out of any marketing communications by clicking on the links at the bottom of every email we send you – including this one! If, for any reason, you would rather not be contacted anymore, please unsubscribe below now. |
||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Visit our Website www.adipogen.com
|
||||||||||||||||||||||||||||||||||||||||||||||
For Ordering please visit: www.adipogen.com Adipogen Life Sciences | info@adipogen.com | Privacy Policy Products are for research use only. Not for human therapeutics or diagnostics use. Manage my Subscription Preferences Unsubscribe - I would like to be removed from this mailing list! Unsubscribe |